Mitochondria and vascular pathology

Pharmacological Reports

Volumn 61, Issue 1, 2009, Pages 123-130

  Di Lisa, Fabio ^a,b   Kaludercic, Nina ^a   Carpi, Andrea ^a   Menabò, Roberta ^b   Giorgio, Marco ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Mitochondria; Monoamine oxidase; Oxidative stress; p66Shc

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CELL PROTEIN; CLORGYLINE; IPRONIAZID; LAZABEMIDE; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; PROTEIN P66SHC; REACTIVE OXYGEN METABOLITE; SELEGILINE; TRANYLCYPROMINE; UNCLASSIFIED DRUG;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL DAMAGE; CELL DEATH; CELL TYPE; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG CLASSIFICATION; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HUMAN; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MOOD DISORDER; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; RESPIRATORY CHAIN; RISK FACTOR; STROKE; TUBERCULOSIS; VASCULAR DISEASE;

EID: 66949176522     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70014-3     Document Type: Conference Paper

References (79)

1. +/- mouse hearts. Circulation, 2002, 105, 981-986.
2. Aulak KS, Miyagi M, Yan L, West KA, Massillon D, Crabb JW, Stuehr DJ: Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci USA, 2001, 98, 12056-12061.
3. Balaban RS, Nemoto S, Finkel T: Mitochondria, oxidants, and aging. Cell, 2005, 120, 483-495.
4. Bauersachs J, Widder JD: Endothelial dysfunction in heart failure. Pharmacol Rep, 2008, 60, 119-126.
5. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol, 1996, 271, C1424-C1437.
6. Beltran B, Mathur A, Duchen MR, Erusalimsky JD, Moncada S: The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc Natl Acad Sci USA, 2000, 97, 14602-14607.
7. Bernardi P, Krauskopf A, Basso E, Petronilli V, Blachly-Dyson E, Di Lisa F, Forte MA: The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J, 2006, 273, 2077-2099.
8. Bernardi P, Petronilli V, Di Lisa F, Forte M: A mitochondrial perspective on cell death. Trends Biochem Sci, 2001, 26, 112-117.
9. Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L, Seguelas MH et al.: Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation, 2005, 112, 3297-3305.
10. Bianchi P, Pimentel DR, Murphy MP, Colucci WS, Parini A: A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation. FASEB J, 2005, 19, 641-643.
11. Binda C, Newton-Vinson P, Hubálek F, Edmondson DE, Mattevi A: Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol, 2002, 9, 22-26.
12. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS: Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol, 2004, 287, C817-C833.
13. Brown GC, Cooper CE: Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett, 1994, 356, 295-298.
14. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA: Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science, 1993, 262, 578-580.
15. Cadenas E, Davies KJ: Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med, 2000, 29, 222-230.
16. Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA, 2007, 104, 5217-5222.
17. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U et al.: Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science, 1995, 268, 1763-1766.
18. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D: Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science, 2008, 321, 1493-1495.
19. Chen Z, Siu B, Ho YS, Vincent R, Chua CC, Hamdy RC, Chua BH: Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol, 1998, 30, 2281-2289.
20. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH: Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett, 1994, 345, 50-54.
21. Coatrieux C, Sanson M, Negre-Salvayre A, Parini A, Hannun Y, Itohara S, Salvayre R, Auge N: MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway. Free Radic Biol Med, 2007, 43, 80-89.
22. Cosentino F, Francia P, Camici GG, Pelicci PG, Luscher TF, Volpe M: Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arterioscler Thromb Vasc Biol, 2008, 28, 622-628.
23. Costantini P, Chernyak BV, Petronilli V, Bernardi P: Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem, 1996, 271, 6746-6751.
24. Costantini P, Chernyak BV, Petronilli V, Bernardi P: Selective inhibition of the mitochondrial permeability transition pore at the oxidation-reduction sensitive dithiol by monobromobimane. FEBS Lett, 1995, 362, 239-242.
25. Daiber A, Wenzel P, Oelze M, Schuhmacher S, Jansen T, Munzel T: Mitochondrial aldehyde dehydrogenase (ALDH-2)-Maker of and marker for nitrate tolerance in response to nitroglycerin treatment. Chem Biol Interact, 2009, 178, 40-47.
26. Davidson SM, Duchen MR: Endothelial mitochondria: contributing to vascular function and disease. Circ Res, 2007, 100, 1128-1141.
27. De Colibus L, Li M, Binda C, Lustig A, Edmondson DE, Mattevi A: Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci USA, 2005, 102, 12684-12689.
28. Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E, Wiernsperger N, Leverve X: Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes, 2005, 54, 2179-2187.
29. Di Lisa F, Bernardi P: Mitochondria and ischemia-reperfusion injury of the heart: Fixing a hole. Cardiovasc Res, 2006, 70, 191-199.
30. Di Lisa F, Bernardi P: Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition. Cardiovasc Res, 2005, 66, 222-232.
31. Di Lisa F, Blank PS, Colonna R, Gambassi G, Silverman HS, Stern MD, Hansford RG: Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J Physiol, 1995, 486, 1-13.
32. Di Lisa F, Menabò R, Canton M, Petronilli V: The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim Biophys Acta, 1998, 1366, 69-78.
33. Droge W: Free radicals in the physiological control of cell function. Physiol Rev, 2002, 82, 47-95.
34. Duchen MR: Mitochondria and calcium: from cell signalling to cell death. J Physiol, 2000, 529, 57-68.
35. Dworakowski R, Alom-Ruiz SP, Shah AM: NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol Rep, 2008, 60, 21-28.
36. Edmondson DE, Binda C, Mattevi A: The FAD binding sites of human monoamine oxidases A and B. Neurotoxicology, 2004, 25, 63-72.
37. Edmondson DE, Mattevi A, Binda C, Li M, Hubalek F: Structure and mechanism of monoamine oxidase. Curr Med Chem, 2004, 11, 1983-1994.
38. Fridovich I: Superoxide radical and superoxide dismutases. Annu Rev Biochem, 1995, 64, 97-112.
39. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G et al.: Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell, 2005, 122, 221-233.
40. Głab M, Łojek A, Wrzosek A, Dołowy K, Szewczyk A: Endothelial mitochondria as a possible target for potassium channel modulators. Pharmacol Rep, 2006, 58, Suppl, 89-95.
41. Gordon LI, Burke MA, Singh AT, Prachand S, Lieberman ED, Sun L, Naik TJ et al.: Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways. J Biol Chem, 2009, 284, 2080-2087.
42. Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A: Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res, 2006, 99, 924-932.
43. Hajnóczky G, Pacher P, Lin X: Spatio-temporal organization of the mitochondrial phase of apoptosis. IUBMB Life, 2001, 52, 237-245.
44. Haynes V, Elfering SL, Squires RJ, Traaseth N, Solien J, Ettl A, Giulivi C: Mitochondrial nitric-oxide synthase: role in pathophysiology. IUBMB Life, 2003, 55, 599-603.
45. Hengartner MO: The biochemistry of apoptosis. Nature, 2000, 407, 770-776.
46. Kaludercic N, Feng N, Nagayama T, Bedja D, Carpi A, Vecoli C, Cormaci G et al.: Monoamine oxidase A is upregulated in cardiac hypertrophy and is a major determinant of the transition from compensation to failure. Circ Res, 2007, 101(11), 7 (abstract).
47. Lemasters JJ, Qian T, Bradham CA, Brenner DA, Cascio WE, Trost LC, Nishimura Y et al.: Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J Bioenerg Biomembr, 1999, 31, 305-319.
48. Lenders JW, Eisenhofer G, Abeling NG, Berger W, Murphy DL, Konings CH, Wagemakers LM et al.: Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Invest, 1996, 97, 1010-1019.
49. Levitt P, Pintar JE, Breakefield XO: Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc Natl Acad Sci USA, 1982, 79, 6385-6389.
50. Madamanchi NR, Runge MS: Mitochondrial dysfunction in atherosclerosis. Circ Res, 2007, 100, 460-473.
51. Maurel A, Hernandez C, Kunduzova O, Bompart G, Cambon C, Parini A, Frances B: Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats. Am J Physiol Heart Circ Physiol, 2003, 284, H1460-H1467.
52. Melov S, Coskun PE, Wallace DC: Mouse models of mitochondrial disease, oxidative stress, and senescence. Mutat Res, 1999, 434, 233-242.
53. Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M et al.: Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes, 2006, 55, 1642-1650.
54. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG: The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature, 1999, 402, 309-313.
55. Migliaccio E, Giorgio M, Pelicci PG: Apoptosis and aging: role of p66Shc redox protein. Antioxid Redox Signal, 2006, 8, 600-608.
56. Murphy MP: How mitochondria produce reactive oxygen species. Biochem J, 2009, 417, 105-111.
57. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M et al.: Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA, 2003, 100, 2112-2116.
58. Newmeyer DD, Ferguson-Miller S: Mitochondria: releasing power for life and unleashing the machineries of death. Cell, 2003, 112, 481-490.
59. Ohashi M, Runge MS, Faraci FM, Heistad DD: MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arterioscler Thromb Vasc Biol, 2006, 26, 2331-2336.
60. Okado-Matsumoto A, Fridovich I: Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J Biol Chem, 2001, 276, 38388-38393.
61. Orrenius S, Zhivotovsky B, Nicotera P: Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol, 2003, 4, 552-565.
62. Orsini F, Migliaccio E, Moroni M, Contursi C, Raker VA, Piccini D, Martin-Padura I et al.: The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem, 2004, 279, 25689-25695.
63. Papa S, Skulachev VP: Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem, 1997, 174, 305-319.
64. Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, Seif I et al.: Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res, 2007, 100, 41-49.
65. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, Contursi C et al.: Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science, 2007, 315, 659-663.
66. Pletscher A: The discovery of antidepressants: a winding path. Experientia, 1991, 47, 4-8.
67. Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, Boveris A: Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys, 1996, 328, 85-92.
68. Riederer P, Lachenmayer L, Laux G: Clinical applications of MAO-inhibitors. Curr Med Chem, 2004, 11, 2033-2043.
69. Rizzuto R, Pinton P, Ferrari D, Chami M, Szabadkai G, Magalhaes PJ, Di Virgilio F, Pozzan T: Calcium and apoptosis: facts and hypotheses. Oncogene, 2003, 22, 8619-8627.
70. Rota M, LeCapitaine N, Hosoda T, Boni A, De Angelis A, Padin-Iruegas ME, Esposito G et al.: Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res, 2006, 99, 42-52.
71. Rouslin W, Erickson JL, Solaro RJ: Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle. Am J Physiol Heart Circ Physiol, 1986, 250, H503-H508.
72. Sarkela TM, Berthiaume J, Elfering S, Gybina AA, Giulivi C: The modulation of oxygen radical production by nitric oxide in mitochondria. J Biol Chem, 2001, 276, 6945-6949.
73. Shih JC: Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. Neurotoxicology, 2004, 25, 21-30.
74. Sivasubramaniam SD, Finch CC, Rodriguez MJ, Mahy N, Billett EE: A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissues. Cell Tissue Res, 2003, 313, 291-300.
75. Tipton KF, Boyce S, O'Sullivan J, Davey GP, Healy J: Monoamine oxidases: certainties and uncertainties. Curr Med Chem, 2004, 11, 1965-1982.
76. Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E, Milia E et al.: A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene, 2002, 21, 3872-3878.
77. Turrens JF: Mitochondrial formation of reactive oxygen species. J Physiol, 2003, 552, 335-344.
78. Wenzel P, Muller J, Zurmeyer S, Schuhmacher S, Schulz E, Oelze M, Pautz A et al.: ALDH-2 deficiency increases cardiovascular oxidative stress-evidence for indirect antioxidative properties. Biochem Biophys Res Commun, 2008, 367, 137-143.
79. Youdim MB, Edmondson D, Tipton KF: The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci, 2006, 7, 295-309.